Abstract
To examine the relationship between costs of hyperglycaemia drug treatment and glycemic control amongst people with type 2 diabetes (T2D). This observational study utilised data from the QUALIDIAB database on 3,452 T2D patients seen in Diabetes Centers in Argentina. Patients were classified according to their HbA1c value into two groups: on target (OT; HbA1c ≤ 7%), and not on target (NOT; HbA1c > 7%); within each category we considered clinical and metabolic indicators, as well as type of hyperglycaemia treatment. Monthly expenditure on drugs was estimated by micro-costing. Multivariable regression analysis was used to evaluate the association between cost of hyperglycaemia treatment and HbA1c values. In total, 48.9% of the participants have HbA1c OT values. Overall monthly per capita costs of this treatment increased significantly (134%) in the NOT group. Multivariable regression analysis showed that expenditure for hyperglycaemia drugs treatment was significant associated with glycemic control (OR: 0.705), diabetes duration (OR: 1.017), systolic blood pressure (OR: 1.006) and treatment of T2D (OR: 2.622). HbA1c NOT significantly increases drugs monthly cost of hyperglycaemia treatment in people with T2D in a country with an e...Continue Reading
References
Feb 15, 2001·JAMA : the Journal of the American Medical Association·E H WagnerL C Grothaus
Feb 24, 2001·Diabetes Care·J MenzinR Cavanaugh
May 26, 2001·Diabetes Care·J J GagliardinoUNKNOWN PENDID-LA Research Group
Jan 5, 2002·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·J J GagliardinoUNKNOWN Grupo de Investigación de la Red QUALIDIAB
Jul 24, 2002·Diabetologia·R WilliamsUNKNOWN CODE-2 Advisory Board
Oct 19, 2002·BMJ : British Medical Journal·Alastair GrayUNKNOWN United Kingdom Prospective Diabetes Study (UKPDS) Group
Jan 31, 2003·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Jun 27, 2003·The New England Journal of Medicine·Elizabeth A McGlynnEve A Kerr
Jul 29, 2003·Diabetes Care·Andrew J KarterUNKNOWN Translating Research Into Action for Diabetes Study Group
Sep 27, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·C M RendersG van der Wal
Jun 22, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T Ozturk KaygusuzS Felek
Jan 18, 2006·Cost Effectiveness and Resource Allocation : C/E·Alan K OglesbyMaureen J Lage
Apr 25, 2006·Journal of Diabetes and Its Complications·Andrea MorsanuttoLorenzo Giovanni Mantovani
Apr 5, 2008·Medical Care·Gregory A NicholsWilliam H Herman
Jul 20, 2011·Journal of Diabetes·Earl S Ford
May 15, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·J J GagliardinoUNKNOWN PRODIACOR
Nov 20, 2013·International Journal of Clinical Practice·V CommendatoreUNKNOWN DIFAR Academic Committee
Sep 6, 2014·International Journal of Public Health·Jorge F ElgartJuan José Gagliardino
Dec 30, 2014·Diabetes Care·Silvio E InzucchiDavid R Matthews
Jul 1, 2002·Diabetologia·R WilliamsC Lucioni
Jul 22, 2017·Diabetes, Obesity & Metabolism·Adrian H HealdAnthony A Fryer